Antimicrobial resistance among neonatal pathogens in developing countries

Pediatric Infectious Disease Journal

Volumn 28, Issue SUPPL. 1, 2009, Pages

  Thaver, Durrane ^a   Ali, Syed Asad ^a   Zaidi, Anita K M ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Antimicrobial resistance; Community; Developing country; Neonatal infections

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; GENTAMICIN; METICILLIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; COMMUNICABLE DISEASE; CONTROLLED STUDY; DEVELOPING COUNTRY; ESCHERICHIA COLI; HUMAN; INFORMATION RETRIEVAL; KLEBSIELLA; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; PNEUMONIA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; BACTERIAL INFECTION; INFANT; MICROBIOLOGY; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN;

EID: 58949103423     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181958780     Document Type: Article

References (22)

1. Archibald LK, Reller LB. Clinical microbiology in developing countries. Emerg Infect Dis. 2001;7:302-305.
2. Herva E, Sombrero L, Lupisan S, et al. Establishing a laboratory for surveillance of invasive bacterial infections in a tertiary care government hospital in a rural province in the Philippines. Am J Trop Med Hyg. 1999;60:1035-1040.
3. Zaidi AK, Huskins WC, Thaver D, et al. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175-1188.
4. The World Bank Country Groups by income. -The World Bank-. 2007. Available at: http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0, content- MDK:20421402-pogePK:64133150-piPK:64133175-theSitePK:239419,00. html. Accessed May, 2007.
5. Klein JO. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus, Newborn and Infants. 5th ed. Philadelphia, PA: WB Saunders; 2001:943-984.
6. Adhikari M, Coovadia YM, Singh D. A 4-year study of neonatal meningitis: clinical and microbiological findings. J Trop Pediatr. 1995;41:81- 85.
7. Kuruvilla KA, Pillai S, Jesudason M, et al. Bacterial profile of sepsis in a neonatal unit in south India. Indian Pediatr. 1998;35:851- 858.
8. Lehmann D, Michael A, Omena M, et al. Bacterial and viral etiology of severe infection in children less than three months old in the highlands of Papua New Guinea. Pediatr Infect Dis J. 1999;18(suppl 10):S42-S49.
9. Muhe L, Tilahun M, Lulseged S, et al. Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediatr Infect Dis J. 1999;18(suppl 10):S56 -S61.
10. Laving AM, Musoke RN, Wasunna AO, et al. Neonatal bacterial meningitis at the newborn unit of Kenyatta National Hospital. East Afr Med J. 2003;80: 456-462.
11. Adejuyigbe EA, ko-Nai AK, Adisa B. Bacterial isolates in the sick young infant in Ile-Ife, Nigeria. J Trop Pediatr. 2004;50:323-327.
12. Quiambao BP, Simoes EA, Ladesma EA, et al. Serious community-acquired neonatal infections in rural Southeast Asia (Bohol Island, Philippines). J Perinatol. 2007;27:112-119.
13. Milledge J, Calis JC, Graham SM, et al. Aetiology of neonatal sepsis in Blantyre, Malawi: 1996 -2001. Ann Trop Paediatr. 2005;25:101-110.
14. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657- 686.
15. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006;34(suppl 1):S20 -S28.
16. Sehgal R, Gaind R, Chellani H, et al. Extended-spectrum beta lactamaseproducing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit. Ann Trop Paediatr. 2007;27:45-54.
17. Pitout JD, Nordmann P, Laupland KB, et al. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52-59.
18. Arslan H, Azap OK, Ergonul O, et al. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005;56:914-918.
19. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob. 2007;6:4.
20. Marijan T, Vranes J, Bedenic B, et al. Emergence of uropathogenic extendedspectrum beta lactamases-producing Escherichia coli strains in the community. Coll Antropol. 2007;31:227-233.
21. Minarini LA, Gales AC, Palazzo IC, et al. Prevalence of communityoccurring extended spectrum beta-lactamase-producing enterobacteriaceae in Brazil. Curr Microbiol. 2007;54:335-341.
22. Randrianirina F, Soares JL, Carod JF, et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother. 2007;59:309 -312.